Recent Finacing
Recent Raise
SphynKx Therapeutics is a drug discovery company developing small-molecule modulators of the sphingosine‑1‑phosphate (S1P) pathway for potential fibrosis and cancer therapies.
Focus Areas
Recent Investors
Total Raised
Funding round
Investor